Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1746.50x is 99% below its 1-year average of -877.31x, near the low end of its 1-year range (-1746.50x–-8.13x).
As of the fiscal period ended Monday, December 31, 2012.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
-1746.50x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.54x
median of 450 covered companies
CURRENT VS SECTOR MEDIAN
-31425.27%
vs the sector median at left
Immunic, Inc.
Market Cap
$109.02M
Interest Coverage Ratio
-1746.50x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$110.33M
Interest Coverage Ratio
-1.15x
TTM Avg
4.51x
3Y Avg
6.93x
5Y Avg
222.11x
Market Cap
$111.27M
Interest Coverage Ratio
N/A
TTM Avg
30.61x
3Y Avg
29.12x
5Y Avg
24.09x
Market Cap
$110.73M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$109.34M
Interest Coverage Ratio
-236.86x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$108.84M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$108.11M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$110.43M
Interest Coverage Ratio
-280.53x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immunic, Inc. (IMUX) | $109.02M | -1746.50x | N/A | N/A | N/A |
| Apyx Medical Corporation (APYX)vs › | $110.33M | -1.15x | 4.51x | 6.93x | 222.11x |
| BGM Group Ltd. (BGM)vs › | $111.27M | N/A | 30.61x | 29.12x | 24.09x |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $110.73M | N/A | N/A | N/A | N/A |
| Outlook Therapeutics, Inc. (OTLK)vs › | $109.34M | -236.86x | N/A | N/A | N/A |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $108.84M | N/A | N/A | N/A | N/A |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.11M | N/A | N/A | N/A | N/A |
| MaxCyte, Inc. (MXCT)vs › | $114.08M | N/A | N/A | N/A | N/A |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $110.43M | -280.53x | N/A | N/A | N/A |
| Lucid Diagnostics Inc. (LUCD)vs › | $115.09M | -2256.36x | N/A | N/A | N/A |
Interest Coverage
-1746.5x
Debt/Equity
0.00
Current Ratio
5.05
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2012-12-31 | -1746.50x |
| 2012-09-30 | -8.13x |
